ReviewFrontiers in medicine2019

Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events.

Yoshiyuki NakamuraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.